KYMERA THERAPEUTICS INC COM is a security (CUSIP 501575104) tracked across SEC portfolio filings. 269 institutional managers reported $7.1B on Form 13F as of 2026-06-30; 52 registered fund positions totaling $1.2B via N-PORT as of 2026-05-31.
Showing 15 of 269 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| FMR LLC | BOSTON, MA | $974.5M | 11,699,950 |
| BAKER BROS. ADVISORS LP | NEW YORK, NY | $721.1M | 8,657,242 |
| Avoro Capital Advisors LLC | New York, NY | $622.6M | 7,474,747 |
| VANGUARD GROUP INC | Valley Forge, PA | $487.7M | 6,267,644 |
| BVF INC/IL | San Francisco, CA | $458.3M | 5,502,710 |
| BlackRock, Inc. | New York, NY | $421.5M | 5,060,876 |
| Atlas Venture Life Science Advisors, LLC | Cambridge, MA | $381.3M | 4,578,008 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $324.0M | 3,889,687 |
| Siren, L.L.C. | New York, NY | $265.4M | 3,186,830 |
| STATE STREET CORP | BOSTON, MA | $199.0M | 2,389,767 |
| Capital Research Global Investors | Los Angeles, CA | $139.4M | 1,673,275 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $137.1M | 1,645,350 |
| Driehaus Capital Management LLC | Chicago, IL | $86.9M | 1,043,583 |
| UBS Group AG | Zurich, V8 | $85.3M | 1,023,852 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $74.0M | 888,409 |
Showing 15 of 52 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| Fidelity Growth Company Fund | Fidelity Mt. Vernon Street Trust | $177.9M | 18.01% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $162.2M | 127.00% |
| VANGUARD HEALTH CARE FUND | VANGUARD SPECIALIZED FUNDS | $145.6M | 39.51% |
| SMALLCAP World Fund Inc | SMALLCAP World Fund Inc | $123.8M | 15.27% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $83.5M | 76.64% |
| T. Rowe Price Small-Cap Stock Fund, Inc. | T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | $65.9M | 81.63% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $57.1M | 7.01% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $51.5M | 23.67% |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | T. ROWE PRICE MID-CAP GROWTH FUND, INC. | $43.7M | 19.41% |
| Fidelity Contrafund | Fidelity Contrafund | $42.1M | 2.67% |
| T. Rowe Price Institutional Small-Cap Stock Fund | T. Rowe Price Equity Funds, Inc. | $35.6M | 82.22% |
| T. Rowe Price All-Cap Opportunities Fund | T. Rowe Price All-Cap Opportunities Fund, Inc. | $32.4M | 22.54% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $24.0M | 13.68% |
| Fidelity Advisor Health Care Fund | Fidelity Advisor Series VII | $18.2M | 63.18% |
| PGIM Jennison Health Sciences Fund | Prudential Sector Funds, Inc. | $17.6M | 126.45% |